OnDose
Showing 1 - 2 of 2
5-FU Exposure Optimization in CRC Patients
Completed
- Metastatic Colorectal Cancer
- +2 more
-
La Jolla, California
- +4 more
Feb 15, 2022
Colorectal Cancer, Metastatic Trial in United States (Pharmacokinetic 5-FU dose adjustment using OnDose® assay, Standard of
Terminated
- Colorectal Cancer, Metastatic
- Pharmacokinetic 5-FU dose adjustment using OnDose® assay
- Standard of care
-
Birmingham, Alabama
- +57 more
Jan 29, 2013